stockrowIngevity Corporation
NGVT Basic Materials Specialty Chemicals
Ingevity Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 2.71% from fiscal 2024.
- Revenue
- −5.25%
- EPS
- +125.4%
- Free cash flow
- −136.1%
- Total debt
- −14.5%
Quarter to June 2026, against a year earlier
Follow NGVT
Alert me
Ingevity Corporation (NGVT) Revenue
Ingevity Corporation's revenue for fiscal 2025 was $1.2B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $1.2B. Over the past ten years it has ranged from $908.3M (fiscal 2016) to $1.7B (fiscal 2022); the current reading is higher than 45% of that period. Revenue has fallen for 3 consecutive fiscal years. Ingevity Corporation ranks 34th of 58 Specialty Chemicals companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $1.2B | (2.71%) |
| FY2024 | $1.2B | (1.27%) |
| FY2023 | $1.2B | (27.14%) |
| FY2022 | $1.7B | 19.89% |
| FY2021 | $1.4B | 14.42% |
| FY2020 | $1.2B | (5.94%) |
| FY2019 | $1.3B | 14.05% |
| FY2018 | $1.1B | 16.58% |
| FY2017 | $972.4M | 7.06% |
| FY2016 | $908.3M | (5.22%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $314.1M | 21.74% |
| Mar 2026 | $258.0M | 1.14% |
| Dec 2025 | $255.1M | (23.42%) |
| Sep 2025 | $333.1M | 0.48% |
| 42 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CC The Chemours Company compare | $5.8B |
| FUL H. B. Fuller Company compare | $3.6B |
| MTX Minerals Technologies Inc. compare | $2.2B |
| KWR Quaker Houghton compare | $2.0B |
| IOSP Innospec Inc. compare | $1.9B |
| NGVT Ingevity Corporation | $1.2B |
| HWKN Hawkins, Inc. compare | $1.1B |
| WDFC WD-40 Company compare | $688.0M |
| STDN Standard Nuclear Inc compare | — |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on NGVT
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement